10/28/2024
6:36 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
8:08 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
2:25 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024
8:39 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024
7:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024
8:13 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
1:40 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
09/16/2024
8:04 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024
8:41 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024
7:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2024
8:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2024
11:15 PM | ImmunoPrecise Antibodies (Filer)
| Form EFFECT | |
08/06/2024
4:16 PM | ImmunoPrecise Antibodies (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
07/30/2024
12:57 PM | ImmunoPrecise Antibodies (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/29/2024
7:35 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024
7:38 AM | ImmunoPrecise Antibodies (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
07/23/2024
8:55 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/16/2024
8:41 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
7:32 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
8:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024
8:12 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2024
12:01 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2024
1:23 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2024
12:21 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
11:02 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
7:21 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
7:00 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
10:19 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/27/2024
9:33 AM | ImmunoPrecise Antibodies (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G | |
02/23/2024
4:26 PM | ImmunoPrecise Antibodies (Filer)
| Form 424B5 | |
02/23/2024
4:29 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/15/2024
2:12 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K/A | |
01/10/2024
12:53 PM | Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
| Form SC 13G/A | |
01/10/2024
12:33 PM | Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
| Form SC 13G | |
12/14/2023
7:48 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
7:38 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023
7:03 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023
4:11 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/07/2023
3:53 PM | ImmunoPrecise Antibodies (Filer)
| Form 424B5 | |
12/06/2023
4:19 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
12/06/2023
6:57 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023
5:01 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023
7:31 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023
4:13 PM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023
7:50 AM | ImmunoPrecise Antibodies (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
